All Stories

  1. Use of UK national health databases for detecting intra-cranial aneurysm rupture in the Risk of Aneurysm Rupture (ROAR) study
  2. Hematoma Interleukin‐1 Receptor Antagonist Concentrations Predict Long‐Term Outcome in Acute Human Intracerebral Hemorrhage
  3. Estimating Rupture Risk of Intracranial Aneurysms: What We Know, What We Do Not Know, and What We Need
  4. Microsurgical management of tentorial dural arteriovenous fistula: an analysis from the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR)
  5. Prospective patient-reported reasons for delayed diagnosis of spontaneous subarachnoid haemorrhage
  6. Appearance and Disappearance of Intracranial Aneurysm Wall Enhancement during Follow-Up: A Multicenter Cohort Study
  7. International survey-based assessment of the reliability, validity, and interpretability of the TDN grade for neurosurgical adverse events
  8. C-reactive protein and fatigue after subarachnoid haemorrhage
  9. Proteomic Discovery Study of Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage
  10. Multicentre study of the role of lumbar puncture in the diagnosis of spontaneous subarachnoid haemorrhage
  11. Discovery of a substantial cerebral venous pressure wave component in Spontaneous Tympanic Membrane Displacement: Expanding understanding of composite Aural Pressure Waves
  12. Identifying elective treatment of unruptured intracranial aneurysms using the Hospital Episode Statistics database
  13. Stereotactic radiosurgery versus observation for intracranial low-grade dural arteriovenous fistulas
  14. Factors Affecting Outcomes Following Mini-Craniotomy Evacuation of Primary Chronic Subdural Hematoma: A Single-Center Retrospective Study
  15. Ruptured aneurysm of the medial posterior choroidal artery in the pineal region: A rare location easily missed
  16. Distinct Cytokine Responses in Central and Systemic Compartments after Subarachnoid Haemorrhage
  17. Monitoring of microsurgically and endovascularly treated aneurysms (META): protocol for an international multicentre retrospective cohort study
  18. Acetylsalicylic acid and subarachnoid hemorrhage in the Nurses’ Health Study
  19. Factors affecting outcomes following burr hole drainage of chronic subdural hematoma: a single-center retrospective study
  20. Early analysis of data from the British & Irish Brain Arteriovenous Malformations Registry (BIBAR)
  21. Cranial Nerve Palsies and Peri-Mesencephalic Subarachnoid Haemorrhage: A Case Report and Review of the Literature
  22. Computational fluid dynamics and shape analysis enhance aneurysm rupture risk stratification
  23. Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
  24. Microsurgical Treatment of Intracranial Dural Arteriovenous Fistulas: A Collaborative Investigation From the Multicenter Consortium for Dural Arteriovenous Fistula Outcomes Research
  25. Quantification of blood and CSF volume to predict outcome after aneurysmal subarachnoid hemorrhage
  26. Clinical practice guidelines for the care of patients with a chronic subdural haematoma: multidisciplinary recommendations from presentation to recovery
  27. A Randomised Controlled Trial of SFX-01 After Subarachnoid Haemorrhage — The SAS Study
  28. Cost-effectiveness of craniotomy versus decompressive craniectomy for UK patients with traumatic acute subdural haematoma
  29. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial
  30. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI)
  31. Basilar artery perforator aneurysms: a comparison with non-perforator saccular aneurysms
  32. A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
  33. Dural arteriovenous fistulas are not observed to convert to a higher grade after partial embolization
  34. Red Blood Cells in the Cerebrospinal Fluid Compartment After Subarachnoid Haemorrhage: Significance and Emerging Therapeutic Strategies
  35. A Systematic Review and Meta-Analysis of the Pathology Underlying Aneurysm Enhancement on Vessel Wall Imaging
  36. An assistive listening device improves hearing following aneurysmal subarachnoid haemorrhage
  37. Gadolinium-enhanced intracranial aneurysm wall imaging and risk of aneurysm growth and rupture: a multicentre longitudinal cohort study
  38. Dural Arteriovenous Fistulas With Cognitive Impairment: Angiographic Characteristics and Treatment Outcomes
  39. The Haptoglobin Response after Aneurysmal Subarachnoid Haemorrhage
  40. Risk of subarachnoid haemorrhage reduces with blood pressure values below hypertensive thresholds
  41. Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage
  42. Protocol for the development of a multidisciplinary clinical practice guideline for the care of patients with chronic subdural haematoma
  43. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma – protocol for the Cavernomas: A Randomised Effectiveness (CARE) pilot trial
  44. Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation
  45. Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma
  46. Aneurysm management in patients over 80 years old with good grade subarachnoid haemorrhage
  47. The VEBAS score: a practical scoring system for intracranial dural arteriovenous fistula obliteration
  48. The association between acetylsalicylic acid and subarachnoid haemorrhage: the Framingham Heart Study
  49. Risk of Aneurysm Rupture (ROAR) study: protocol for a long-term, longitudinal, UK multicentre study of unruptured intracranial aneurysms
  50. Sphingosine-1-phosphate Signalling in Aneurysmal Subarachnoid Haemorrhage: Basic Science to Clinical Translation
  51. Time to evacuation of acute subdural and extradural haematoma: prospective study before and after implementation of a major trauma centre
  52. Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration
  53. Functional effects of haemoglobin can be rescued by haptoglobin in anin vitromodel of subarachnoid haemorrhage
  54. Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices
  55. Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage
  56. Changes in Outcome Prediction During the First Week After Subarachnoid Hemorrhage
  57. A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis
  58. Radiological follow-up of endovascularly treated intracranial aneurysms: a survey of current practice in the UK and Ireland
  59. Genetic variation inNFE2L2is associated with outcome following aneurysmal subarachnoid haemorrhage
  60. Comparison of Suspected and Confirmed Internal External Ventricular Drain-Related Infections: A Prospective Multicenter United Kingdom Observational Study
  61. Long‐term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employment
  62. Natural history, angiographic presentation and outcomes of anterior cranial fossa dural arteriovenous fistulas
  63. Aspirin and Subarachnoid Haemorrhage in the UK Biobank
  64. Evaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months
  65. Risk of Early Versus Later Rebleeding From Dural Arteriovenous Fistulas With Cortical Venous Drainage
  66. Iron Deposition in the Brain After Aneurysmal Subarachnoid Hemorrhage
  67. Assessing the rate, natural history, and treatment trends of intracranial aneurysms in patients with intracranial dural arteriovenous fistulas: a Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR) investigation
  68. Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR): rationale, design, and initial characterization of patient cohort
  69. Dural arteriovenous fistulas without cortical venous drainage: presentation, treatment, and outcomes
  70. Intervention for unruptured high-grade intracranial dural arteriovenous fistulas: a multicenter study
  71. Recurrence after cure in cranial dural arteriovenous fistulas: a collaborative effort by the Consortium for Dural Arteriovenous Fistula Outcomes Research (CONDOR)
  72. Auditory outcome following aneurysmal subarachnoid haemorrhage
  73. Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: Protocol
  74. Pulsatile tympanic membrane displacement is associated with cognitive score in healthy subjects
  75. Long-Term Cognitive Outcome following Aneurysmal Subarachnoid Haemorrhage
  76. A survey of the radiological follow-up of unruptured intracranial aneurysms in the United Kingdom
  77. CRP (C-Reactive Protein) in Outcome Prediction After Subarachnoid Hemorrhage and the Role of Machine Learning
  78. Outcome Following Hemorrhage From Cranial Dural Arteriovenous Fistulae
  79. Estimating confidence intervals for cerebral autoregulation: a parametric bootstrap approach
  80. Utility of image-guided external ventriculostomy: analysis of contemporary practice in the United Kingdom and Ireland
  81. Psychological distress after subarachnoid haemorrhage: A systematic review and meta-analysis
  82. Age-related changes in Tau and Autophagy in human brain in the absence of neurodegeneration
  83. First Report of a Multicenter Prospective Registry of Cranioplasty in the United Kingdom and Ireland
  84. Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI Study
  85. A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population
  86. Onyx embolization for dural arteriovenous fistulas: a multi-institutional study
  87. Observation Versus Intervention for Low-Grade Intracranial Dural Arteriovenous Fistulas
  88. Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage
  89. ANGPTL6 Genetic Variants Are an Underlying Cause of Familial Intracranial Aneurysms
  90. A vascular subtraction method for improving the variability of evoked tympanic membrane displacement measurements
  91. Neurofilament light predicts neurological outcome after subarachnoid haemorrhage
  92. Sonic Hedgehog Signaling Promotes Peri-Lesion Cell Proliferation and Functional Improvement after Cortical Contusion Injury
  93. Trial of Dexamethasone for Chronic Subdural Hematoma
  94. Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
  95. Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors
  96. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial
  97. Intracranial Masson Lesion Following Stereotactic Radiosurgery for Treatment of Intracranial Arteriovenous Malformations
  98. Assessment of the Subarachnoid Hemorrhage International Trialists (SAHIT) Models for Dichotomized Long-Term Functional Outcome Prediction After Aneurysmal Subarachnoid Hemorrhage in a United Kingdom Multicenter Cohort Study
  99. Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons
  100. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
  101. Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
  102. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study
  103. Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)
  104. Vasomotion Drives Periarterial Drainage of Aβ from the Brain
  105. Age dependent changes in synaptic NMDA receptor composition in adult human cortical neurons
  106. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study
  107. Haptoglobin genotype and outcome after aneurysmal subarachnoid haemorrhage
  108. Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage
  109. Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin
  110. Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA)
  111. Time to surgery following chronic subdural hematoma: post hoc analysis of a prospective cohort study
  112. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial
  113. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation
  114. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage
  115. A primate-specific short GluN2A-NMDA receptor isoform is expressed in the human brain
  116. Vessel Wall Imaging After Subarachnoid Hemorrhage in Patients with Multiple Intracranial Aneurysms: A Cautionary Case
  117. Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury
  118. Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential
  119. Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
  120. Haptoglobin genotype and aneurysmal subarachnoid hemorrhage
  121. Image guidance and improved accuracy of external ventricular drain tip position particularly in patients with small ventricles
  122. Current epidemiology of cerebrospinal fluid shunt surgery in the UK and Ireland (2004–2013)
  123. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure
  124. Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
  125. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
  126. Safety, accuracy, and cost effectiveness of bedside bolt external ventricular drains (EVDs) in comparison to tunnelled EVDs inserted in theatres
  127. Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
  128. How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?
  129. Hearing impairment after subarachnoid hemorrhage
  130. In-VivoHyperspectral Human Brain Image Database for Brain Cancer Detection
  131. SVM Optimization for Brain Tumor Identification Using Infrared Spectroscopic Samples
  132. Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial
  133. BRIDGING THE GAP – BENEFITS OF NEUROSURGICAL TISSUE FOR PRE-CLINICAL RESEARCH
  134. Pharmacological management of post-traumatic seizures in adults: current practice patterns in the UK and the Republic of Ireland
  135. Does Drain Position and Duration Influence Outcomes in Patients Undergoing Burr-Hole Evacuation of Chronic Subdural Hematoma? Lessons from a UK Multicenter Prospective Cohort Study
  136. Quantifying the contribution of intracranial pressure and arterial blood pressure to spontaneous tympanic membrane displacement
  137. Corrigendum to “Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis”
  138. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications
  139. Anatomy of spaces around blood vessels in cerebral amyloid angiopathy
  140. Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma
  141. The Wessex modified Richmond Sedation Scale as a novel tool for monitoring patients at risk of malignant MCA syndrome
  142. Outcomes of Microsurgical Clipping of Recurrent Aneurysms After Endovascular Coiling
  143. Spatio-spectral classification of hyperspectral images for brain cancer detection during surgical operations
  144. Refining non-invasive techniques to measure intracranial pressure: comparing evoked and spontaneous tympanic membrane displacements
  145. A subarachnoid haemorrhage-specific outcome tool
  146. An Intraoperative Visualization System Using Hyperspectral Imaging to Aid in Brain Tumor Delineation
  147. An Evaluation of Commonly Used External Ventricular Drain Securement Methods in a Porcine Model: Recommendations to Improve Practice
  148. Reference intervals for the evoked tympanic membrane displacement measurement: a non-invasive measure of intracranial pressure
  149. Association of functional MMP-2 gene variant with intracranial aneurysms: case-control genetic association study and meta-analysis
  150. Does the Variability of Evoked Tympanic Membrane Displacement Data (V m) Increase as the Magnitude of the Pulse Amplitude Increases?
  151. Mentoring models in neurosurgical training: Review of literature
  152. Degree and Duration of Functional Improvement on Long-Term Follow-Up of Spinal Dural Arteriovenous Fistulae Occluded by Endovascular and Surgical Treatment
  153. The Resolution of Oculomotor Nerve Palsy Caused by Unruptured Posterior Communicating Artery Aneurysms: A Cohort Study and Narrative Review
  154. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland
  155. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom
  156. CSF inflammatory response after intraventricular hemorrhage
  157. What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis
  158. Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case–Control Study
  159. Cholesterol-Reducing Agents for Treatment of Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis of Randomized Controlled Trials
  160. Compliance of systematic reviews articles in brain arteriovenous malformation with PRISMA statement guidelines: Review of literature
  161. P04.20 Hyperspectral imaging for brain tumour identification and boundaries delineation in real-time during neurosurgical operations
  162. Journal Club
  163. Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis
  164. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
  165. The effect of direction of force to the craniofacial skeleton on the severity of brain injury in patients with a fronto-basal fracture
  166. HELICoiD project: a new use of hyperspectral imaging for brain cancer detection in real-time during neurosurgical operations
  167. The use of human neurons for novel drug discovery in dementia research
  168. Heme–Hemopexin Scavenging Is Active in the Brain and Associates With Outcome After Subarachnoid Hemorrhage
  169. Decision tree classification system for brain cancer detection using spectrographic samples
  170. Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage
  171. Pharmacologic Management of Subarachnoid Hemorrhage
  172. Time Course and Risk Factors for Myocardial Dysfunction After Aneurysmal Subarachnoid Hemorrhage
  173. A Clinical Trial of Progesterone for Severe Traumatic Brain Injury
  174. Nitric Oxide Synthase Inhibition with the Antipterin VAS203 Improves Outcome in Moderate and Severe Traumatic Brain Injury: A Placebo-Controlled Randomized Phase IIa Trial (NOSTRA)
  175. External ventricular drainage: Is it time to look at national practice?
  176. Haemoglobin Scavenging After Subarachnoid Haemorrhage
  177. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial
  178. Alternative cost-effective method to record 3D intra-operative images: A technical note
  179. Proposal for establishment of the UK Cranial Reconstruction Registry (UKCRR)
  180. Recovery of oculomotor nerve palsy secondary to posterior communicating artery aneurysms
  181. A 73 Year-Old Man with a Mass at the Foramen Magnum
  182. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial
  183. Surgical management of acute subdural haematomas: current practice patterns in the United Kingdom and the Republic of Ireland
  184. A Randomized Controlled Trial of Prophylactic Intra-aortic Balloon Counterpulsation in High-Risk Aneurysmal Subarachnoid Hemorrhage
  185. Impairment of Cerebral Autoregulation Predicts Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
  186. The Natural History of Cerebral Dural Arteriovenous Fistulae
  187. The SILVER (Silver Impregnated Line Versus EVD Randomized Trial)
  188. A mathematical model of utility for single screening of asymptomatic unruptured intracranial aneurysms at the age of 50 years
  189. Pathological laughter and crying in patients with pontine lesions
  190. Response to: A web-based referral system for neurosurgery; a solution to our problems?
  191. The Natural History of Cranial Dural Arteriovenous Fistulae With Cortical Venous Reflux—The Significance of Venous Ectasia
  192. Neurenteric cyst of the anterior cranial fossa: case report and literature review
  193. Causes of neurological deficits following clipping of 200 consecutive ruptured aneurysms in patients with good-grade aneurysmal subarachnoid haemorrhage
  194. Chordoma of the anterior skull base presenting as a swelling of the medial canthus of the eye
  195. Placement of silicone sheeting at decompressive craniectomy to prevent adhesions at cranioplasty
  196. Visual recovery following optic nerve decompression for chronic compressive neuropathy
  197. A prospective study of the time to evacuate acute subdural and extradural haematomas
  198. Assessment of neurological function
  199. Optical Intraoperative Measurement of Function in the Human Brain
  200. Assessment of neurological function
  201. An alternative method of wound pain control following hepatic resection: a preliminary study
  202. Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region
  203. Opioid receptor regulation of muscarinic acetylcholine receptor-mediated synaptic responses in the hippocampus
  204. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by GABABreceptors in the rat hippocampus
  205. Coincident activation of mGluRs and mAChRs imposes theta frequency patterning on synchronised network activity in the hippocampal CA3 region
  206. Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus